KRAZATI Film-coated tablet Ref.[108847] Active ingredients: Adagrasib

Source: European Medicines Agency (EU)  Revision Year: 2024  Publisher: Mirati Therapeutics B.V., Locatellikade 1, 1076 AZ Amsterdam, Netherlands

Product name and form

KRAZATI 200 mg film-coated tablets.

Pharmaceutical Form

Film-coated tablet.

White to off-white, oval shaped, film-coated tablet, approximately 8 × 16 mm, with a stylised “M” on one side and “200” marked on the other side.

Qualitative and quantitative composition

Each film-coated tablet contains 200 mg adagrasib.

For the full list of excipients, see section 6.1.

Active Ingredient Description

Adagrasib is a selective, irreversible inhibitor of KRAS (Kirsten rat sarcoma viral oncogene homolog) G12C that covalently binds to the mutant cysteine in KRAS G12C and locks the mutant KRAS protein in its inactive, GDP-bound conformation, which prevents KRAS-dependent downstream signalling. Adagrasib inhibits tumour cell growth and viability in cells harbouring KRAS G12C mutations and results in regression in KRAS G12C-positive nonclinical tumour models with minimal off-target activity.

List of Excipients

Tablet core:

Microcrystalline cellulose (E460)
Mannitol (E421)
Silica, colloidal anhydrous (E551)
Magnesium stearate (vegetable)


Titanium dioxide (E171)
Polydextrose (E1200)
Talc (E553b)
Medium chain triglycerides (vegetable)

Pack sizes and marketing

Each carton contains one white opaque HDPE bottle with a white, child resistant polypropylene closure and an aluminium foil heat induction seal. Each HDPE bottle contains two 1 g of silica gel desiccant containers.

Pack sizes: bottles with 120 and 180 film-coated tablets.

Not all pack sizes may be marketed.

Marketing authorization holder

Mirati Therapeutics B.V., Locatellikade 1, 1076 AZ Amsterdam, Netherlands

Marketing authorization dates and numbers



Drug Countries
KRAZATI Austria, Estonia, Croatia, Lithuania, United States

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.